img

#1

US IPO Issuance in 2022 - 2024 YTD3

img

#1

SPAC issuance in 2022 - 2024 YTD2

img

$23B+

in Gross Proceeds Raised3

img

300+

Transactions Completed3

Recent Transactions
img
img
Unicycive Therapeutics Inc.
(Nasdaq: UNCY)

Initial Public Offering
Lead Manager

1 34 35 36
Insights
  • June 17, 2025

    D. Boral Capital acted as Exclusive Placement Agent to Brera Holdings PLC (Nasdaq: BREA) in connection with its $1.4 Million Registered Direct Offering

  • June 11, 2025

    D. Boral Capital acted as Sole Bookrunner to Aduro Clean Technologies Inc. (Nasdaq: ADUR) in connection with its $8.0 Million Follow-on Offering

  • June 10, 2025

    D. Boral Capital acted as Placement Agent in connection with a $4,850,000 Private Placement of SpaceX Series Interests

  • June 2, 2025

    D. Boral Capital Acted as Co-Placement Agent to Medicus Pharma Ltd. (Nasdaq: MDCX) in connection with its $7.0 Million Follow-On Offering

img

Together, let's build meaningful value.